Dietary Supplements for ADHD: A Controlled Trial

J Gordon Millichap

doi:10.15844/pedneurbriefs-15-9-10

Dietary Supplements for ADHD: A Controlled Trial

Pediatric Neurology Briefs

Volume 15 (2001): Issue 9

By: J Gordon Millichap

Open Access

|Sep 2001

Abstract

The effect of docosahexaenoic acid (DHA) supplementation (345 mg/d) on the symptoms of attention deficit/hyperactivity disorder (ADHD) was determined in 63 children, ages 6 to 12 years, at the Mayo Clinic and Baylor College of Medicine, Houston, TX.

References

Voigt RG Llorente AM Jensen CL Fraley JK Berretta MC Heird WC A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder J Pediatr 2001 Aug 139 2 189 96 10.1067/mpd.2001.116050 11487742
Open DOI Search in Google Scholar Back to article
Millichap JG Attention Deficit Hyperactivity and Learning Disorders 2001 PNB Publ
Search in Google Scholar Back to article
Schachar RJ Tannock R Cunningham C Corkum PV Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate J Am Acad Child Adolesc Psychiatry 1997 Jun 36 6 754 63 10.1097/00004583-199706000-00011 9183129
Open DOI Search in Google Scholar Back to article
Kemper KJ Dietary supplements for attention-deficit/hyperactivity disorder--a fishy business? J Pediatr 2001 Aug 139 2 173 4 10.1067/mpd.2001.116932 11487738
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-15-9-10 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 70 - 71

Published on: Sep 1, 2001

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Docosahexaenoic Acid,

Attention Deficit/Hyperactivity Disorder,

Placebo Group

© 2001 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 15 (2001): Issue 9